Evidence map›Paper›PMID 38682582›Full record

ArticleNucleic acids research2024

Senescence of human pancreatic beta cells enhances functional maturation through chromatin reorganization and promotes interferon responsiveness.

Milan Patra, Agnes Klochendler, Reba Condiotti, Binyamin Kaffe, Sharona Elgavish, Zeina Drawshy, Dana Avrahami, Masashi Narita, Matan Hofree, Yotam Drier and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Milan PatraDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0001-6870-9938
Agnes KlochendlerDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Reba CondiottiDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Binyamin KaffeDepartment of Genetics, the Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Sciences (ELSC), The Hebrew University of Jerusalem, Jerusalem, Israel.
Sharona ElgavishInfo-CORE, Bioinformatics Unit of the I-CORE at the Hebrew University of Jerusalem, Jerusalem, Israel.
Zeina DrawshyDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Dana AvrahamiDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Masashi NaritaCancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7764-577X
Matan HofreeThe Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0001-8368-0299
Yotam DrierThe Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0003-1725-2995
Eran MeshorerDepartment of Genetics, the Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Sciences (ELSC), The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0003-4777-986X
Yuval DorDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0003-2456-2289
Ittai Ben-PorathDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0001-7815-1165

Funding

The role of senescent beta cells in T1D and T2DU01DK134995 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KAESTNER, KLAUS H · 2022 to 2025
$2.8M
Survival and potential of insulin-deficient beta cells in type 1 diabetesU01DK135001 · NIDDK · UNIVERSITY OF FLORIDA · PI SCHATZ, DESMOND ARTHUR · 2022 to 2025
$2.8M
RNA editing in islet function and inflammationR01DK133442 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Yuval Dor, Erez Levanon · 2023 to 2026
$2.1M
TOBACCO FLAVOR COMPOUNDSP01CA029580 · NCI · INSTITUTE FOR CANCER PREVENTION · 1985 to 1995
–
British Council BIRAX Program 65BX18MNIBCancer Research UK C9545/A29580Cancer Research UK Cambridge Institute C9545/A29580Deutsches KrebsforschungszentrumDKFZIsrael Science Foundation Legacy Heritage Program 1245/16Juvenile Diabetes Research Fund 3-SRA-2024-1479-S-BMinistry of Science, Technology and Space 0004062NIDDK NIH HHS R01 DK133442NIDDK NIH HHS U01 DK134995NIDDK NIH HHS U01 DK135001Stichting Onderzoek NederlandWalter and Greta Stiel Chair and ResearchWoll Sisters and Brothers Chair in Cardiovascular Diseases
6 · The paper itself

Abstract

Senescent cells can influence the function of tissues in which they reside, and their propensity for disease. A portion of adult human pancreatic beta cells express the senescence marker p16, yet it is unclear whether they are in a senescent state, and how this affects insulin secretion. We analyzed single-cell transcriptome datasets of adult human beta cells, and found that p16-positive cells express senescence gene signatures, as well as elevated levels of beta-cell maturation genes, consistent with enhanced functionality. Senescent human beta-like cells in culture undergo chromatin reorganization that leads to activation of enhancers regulating functional maturation genes and acquisition of glucose-stimulated insulin secretion capacity. Strikingly, Interferon-stimulated genes are elevated in senescent human beta cells, but genes encoding senescence-associated secretory phenotype (SASP) cytokines are not. Senescent beta cells in culture and in human tissue show elevated levels of cytoplasmic DNA, contributing to their increased interferon responsiveness. Human beta-cell senescence thus involves chromatin-driven upregulation of a functional-maturation program, and increased responsiveness of interferon-stimulated genes, changes that could increase both insulin secretion and immune reactivity.

Indexed as

Cellular SenescenceChromatin Assembly and DisassemblyInsulin-Secreting CellsInterferonsCells, CulturedChromatinCyclin-Dependent Kinase Inhibitor p16HumansInsulinInsulin SecretionSenescence-Associated Secretory PhenotypeSingle-Cell AnalysisTranscriptomeChromatinCyclin-Dependent Kinase Inhibitor p16InsulinInterferons

Identifiers

PMID38682582
PMCPMC11194086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.